Mark Leuschner's Contact Details

Mark Leuschner's Company Details

Ionetix Corporation

San Francisco, CA, US • 50 - 99 Employees
Major Drugs

IONETIX is a leading molecular imaging diagnostics and therapeutics company focused on providing physicians and patients access to N-13 Ammonia. Used by a growing number of academic institutions, N-13 Ammonia is rapidly changing the standard of excellence for myocardial perfusion in cardiac PET imaging. By combining our expertise, experience, and cutting-edge infrastructure solution, IONETIX creates new pathways for bringing N-13 Ammonia into your practice. Our innovative dose service model eliminates the up-front expense and provides the support needed to launch a successful cardiac PET program, while helping to establish a brand-differentiating service that keeps patients close and drives referrals. We invite you to explore our website for more information.